Antiangiogenic activity of Tripterygium wilfordii and its terpenoids

Journal of Ethnopharmacology

Volumn 121, Issue 1, 2009, Pages 61-68

  He, Ming Fang ^a   Liu, Lin ^a   Ge, Wei ^a   Shaw, Pang Chui ^a   Jiang, Renwang ^a   Wu, Li Wha ^b   But, Paul Pui Hay ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Angpt2; Antiangiogenesis; Tie2; Tripterygium wilfordii; Triptolide; Zebrafish

Indexed keywords

CANGORONINE; CELASTROL; MESSENGER RNA; TERPENOID; TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; EMBRYO; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT ROOT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ZEBRA FISH;

ANGIOGENESIS INHIBITORS; ANIMALS; DISEASE MODELS, ANIMAL; DITERPENES; DRUGS, CHINESE HERBAL; EMBRYO, NONMAMMALIAN; EPOXY COMPOUNDS; NEOVASCULARIZATION, PHYSIOLOGIC; PHENANTHRENES; PLANT ROOTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TERPENES; TRIPTERYGIUM; TRITERPENES; ZEBRAFISH;

CELASTRACEAE; DANIO RERIO; TRIPTERYGIUM WILFORDII;

EID: 57949095645     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.09.033     Document Type: Article

References (48)

1. Ahn E.K., Jeon H.J., Lim E.J., Jung H.J., and Park E.H. Anti-inflammatory and anti-angiogenic activities of Gastrodia elata Blume. Journal of Ethnopharmacology 110 (2007) 476-482
2. Belleri M., Ribatti D., Nicoli S., Cotelli F., Forti L., Vannini V., Stivala L.A., and Presta M. Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4′-trimethoxystilbene. Molecular Pharmacology 67 (2005) 1451-1459
3. Brinker A.M., Ma J., Lipsky P.E., and Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 68 (2007) 732-766
4. Chan J., Bayliss P.E., Wood J.M., and Roberts T.M. Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 1 (2002) 257-267
5. Chang W.T., Kang J.J., Lee K.Y., Wei K., Anderson E., Gotmare S., Ross J.A., and Rosen G.D. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. Journal of Biological Chemistry 276 (2001) 2221-2227
6. Cross L.M., Cook M.A., Lin S., Chen J.N., and Rubinstein A.L. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arteriosclerosis Thrombosis Vascular Biology 23 (2003) 911-912
7. Deorukhkar A., Krishnan S., Sethi G., and Aggarwal B.B. Back to basics: how natural products can provide the basis for new therapeutics. Expert Opinion on Investigational Drugs 16 (2007) 1753-1773
8. Donnini S., Ziche M., and Morbidelli L. molecular mechanisms of VEGF-induced angiogenesis. In: Harmey J.H. (Ed). VEGF and Cancer (2004), Kluwer Academic/Plenum Publishing, New York 19-25
9. Fan T.P., Yeh J.C., Leung K.W., Yue P.Y., and Wong R.N. Angiogenesis: from plants to blood vessels. Trends in Pharmacological Science 27 (2006) 297-309
10. Fiedler U., and Augustin H.G. Angiopoietins: a link between angiogenesis and inflammation. Trends in Immunology 27 (2006) 552-558
11. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1 (1995) 27-31
12. Fouquet B., Weinstein B.M., Serluca F.C., and Fishman M.C. Vessel patterning in the embryo of the zebrafish: guidance by notochord. Developmental Biology 183 (1997) 37-48
13. Gale N.W., and Yancopoulos G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes and Development 13 (1999) 1055-1066
14. Gupta K., and Zhang J. Angiogenesis: a curse or cure?. Postgraduate Medical Journal 81 (2005) 236-242
15. Hu K.B., Liu Z.H., Liu D., and Li L.S. Inhibition of vascular endothelial growth factor expression and production by triptolide. Planta Medica 68 (2002) 368-369
16. Huang Y.L., Zhou Y.X., Zhou D., Xu Q.N., Ye M., Sun C.F., and Du Z.W. Celastrol in the inhibition of neovascularization. Zhonghua Zhong Liu Za Zhi 25 (2003) 429-432
17. Isenberg J.S., Jia Y., Field L., Ridnour L.A., Sparatore A., Del Soldato P., Sowers A.L., Yeh G.C., Moody T.W., Wink D.A., Ramchandran R., and Roberts D.D. Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. British Journal of Pharmacology 151 (2007) 63-72
18. Jia L. Chemistry and pharmacology and clinical application of the plants of Tripterygium family. Yao Xue Tong Bao 20 (1985) 1001-1005
19. Jung H.J., Jeon H.J., Lim E.J., Ahn E.K., Song Y.S., Lee S., Shin K.H., Lim C.J., and Park E.H. Anti-angiogenic activity of the methanol extract and its fractions of Ulmus davidiana var. japonica. Journal of Ethnopharmacology 112 (2007) 406-409
20. Jung H.J., Kang H.J., Song Y.S., Park E.H., Kim Y.M., and Lim C.J. Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Sedum sarmentosum extract. Journal of Ethnopharmacology 116 (2008) 138-143
21. Kiviharju T.M., Lecane P.S., Sellers R.G., and Peehl D.M. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clinical Cancer Research 8 (2002) 2666-2674
22. Lam H.W., Lin H.C., Lao S.C., Gao J.L., Hong S.J., Leong C.W., Yue P.Y., Kwan Y.W., Leung A.Y., Wang Y.T., and Lee S.M. The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo. Journal of Cellular Biochemistry 103 (2008) 195-211
23. Liang D., Xu X., Chin A.J., Balasubramaniyan N.V., Teo M.A., Lam T.J., Weinberg E.S., and Ge R. Cloning and characterization of vascular endothelial growth factor (VEGF) from zebrafish, Danio rerio. Biochimica et Biophysica Acta 1397 (1998) 14-20
24. Lou Y.J., and Jin J. Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. Leukemia & Lymphoma 45 (2004) 373-376
25. Lyons M.S., Bell B., Stainier D., and Peters K.G. Isolation of the zebrafish homologues for the tie-1 and tie-2 endothelium-specific receptor tyrosine kinases. Developmental Dynamics 212 (1998) 133-140
26. Ma J., Dey M., Yang H., Poulev A., Pouleva R., Dorn R., Lipsky P.E., Kennelly E.J., and Raskin I. Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry 68 (2007) 1172-1178
27. Ma J.S., Brach A.R., and Liu Q.R. A revision of the genus Tripterygium (Celastraceae). Edinburgh Journal of Botany 56 (1999) 33-46
28. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., Sato T.N., and Yancopoulos G.D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
29. Mao Y., Tao X., and Lipsky P.E. Pharmacokinetics of triptolide. Development and application of a high performace liquid chromatographic method for quantitation of triptolide in plasma. Journal of Liquid Chromatography & Related Technologies 9 (1999) 1355-1366
30. Mathur R., Gupta S.K., Singh N., Mathur S., Kochupillai V., and Velpandian T. Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis. Journal of Ethnopharmacology 105 (2006) 336-341
31. Nasevicius A., Larson J., and Ekker S.C. Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast 17 (2000) 294-301
32. Norrby K. In vivo models of angiogenesis. Journal of Cellular and Molecular Medicine 10 (2006) 588-612
33. Parng C., Seng W.L., Semino C., and McGrath P. Zebrafish: a preclinical model for drug screening. Assay and Drug Development Technologies 1 (2002) 41-48
34. Roccaro A.M., Russo F., Cirulli T., Di Pietro G., Vacca A., and Dammacco F. Antiangiogenesis for rheumatoid arthritis. Current Drug Targets-Inflammation & Allergy 4 (2005) 27-30
35. Seng W.L., Eng K., Lee J., and McGrath P. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment. Angiogenesis 7 (2004) 243-253
36. Shibuya M., and Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Experimental Cell Research 312 (2006) 549-560
37. Staton C.A., Stribbling S.M., Tazzyman S., Hughes R., Brown N.J., and Lewis C.E. Current methods for assaying angiogenesis in vitro and in vivo. International Journal of Experimental Pathology 85 (2004) 233-248
38. Stern H.M., and Zon L.I. Cancer genetics and drug discovery in the zebrafish. Nature Reviews Cancer 3 (2003) 533-539
39. Tao X.L., Dong Y., and Zhang N.Z. A double-blind study of T2 (tablets of polyglycosides of Tripterygium wilfodii hook) in the treatment of rheumatoid arthritis. Zhonghua Nei Ke Za Zhi 26 (1987) 399-402 pp. 444-395
40. Taraboletti G., and Giavazzi R. Modelling approaches for angiogenesis. European Journal of Cancer 40 (2004) 881-889
41. Tengchaisri T., Chawengkirttikul R., Rachaphaew N., Reutrakul V., Sangsuwan R., and Sirisinha S. Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. Cancer Letters 133 (1998) 169-175
42. Tran T.C., Sneed B., Haider J., Blavo D., White A., Aiyejorun T., Baranowski T.C., Rubinstein A.L., Doan T.N., Dingledine R., and Sandberg E.M. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Research 67 (2007) 11386-11392
43. Ushiro S., Ono M., Nakayama J., Fujiwara T., Komatsu Y., Sugimachi K., and Kuwano M. New nortriterpenoid isolated from anti-rheumatoid arthritic plant, Tripterygium wilfordii, modulates tumor growth and neovascularization. International Journal of Cancer 72 (1997) 657-663
44. Wang Y., and Ge W. Spatial expression patterns of activin and its signaling system in the zebrafish ovarian follicle: evidence for paracrine action of activin on the oocytes. Biology of Reproduction 69 (2003) 1998-2006
45. Wang Z., Zheng L., Yang S., Niu R., Chu E., and Lin X. N-acetylchitooligosaccharide is a potent angiogenic inhibitor both in vivo and in vitro. Biochemical and Biophysical Research Communications 357 (2007) 26-31
46. Westerfield, M., 1993. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish. University of Oregon Press, Eugene, OR.
47. Yang S., Chen J., Guo Z., Xu X.M., Wang L., Pei X.F., Yang J., Underhill C.B., and Zhang L. Triptolide inhibits the growth and metastasis of solid tumors. Molecular Cancer Therapeutics 2 (2003) 65-72
48. Ziche M., Donnini S., and Morbidelli L. Development of new drugs in angiogenesis. Current Drug Targets 5 (2004) 485-493